Found: 29
Select item for more details and to access through your institution.
Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD‐11.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2819, doi. 10.1111/dom.14533
- By:
- Publication type:
- Article
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2279, doi. 10.1111/dom.14469
- By:
- Publication type:
- Article
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 798, doi. 10.1111/dom.13958
- By:
- Publication type:
- Article
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2379, doi. 10.1111/dom.13377
- By:
- Publication type:
- Article
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 791, doi. 10.1111/dom.12877
- By:
- Publication type:
- Article
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 78, doi. 10.1111/dom.12786
- By:
- Publication type:
- Article
Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 10, p. 2783, doi. 10.1007/s13300-021-01140-9
- By:
- Publication type:
- Article
Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 8, p. 2223, doi. 10.1007/s13300-021-01110-1
- By:
- Publication type:
- Article
Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01802-x
- By:
- Publication type:
- Article
Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials.
- Published in:
- Cardiovascular Therapeutics, 2010, v. 28, n. 2, p. 124, doi. 10.1111/j.1755-5922.2010.00146.x
- By:
- Publication type:
- Article
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 8, p. e3448, doi. 10.1210/clinem/dgac200
- By:
- Publication type:
- Article
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1805, doi. 10.1002/ejhf.2670
- By:
- Publication type:
- Article
Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0933-y
- By:
- Publication type:
- Article
Insulin analogues: new therapies for type 2 diabetes mellitus.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study.
- Published in:
- Journal of Clinical Hypertension, 2012, v. 14, n. 10, p. 731, doi. 10.1111/j.1751-7176.2012.00687.x
- By:
- Publication type:
- Article
Progression of glucose‐lowering diabetes therapy in TECOS.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1002/edm2.53
- By:
- Publication type:
- Article
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 1046, doi. 10.2337/dc22-2397
- By:
- Publication type:
- Article
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11).
- Published in:
- 2021
- By:
- Publication type:
- journal article
HbA<sub>1c</sub> Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pancreatic Safety of Sitagliptin in the TECOS Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of a Self-Administered Oral Glucose Tolerance Test.
- Published in:
- Diabetes Care, 2013, v. 36, n. 6, p. 1483, doi. 10.2337/dc12-0643
- By:
- Publication type:
- Article
Costs of the Metabolic Syndrome in Elderly Individuals.
- Published in:
- Diabetes Care, 2007, v. 30, n. 10, p. 2553, doi. 10.2337/dc07-0460
- By:
- Publication type:
- Article